Strömbom U
Naunyn Schmiedebergs Arch Pharmacol. 1976;292(2):167-76. doi: 10.1007/BF00498588.
Motor activity during the first 5 min in a motility meter was measured in mice given 0.025-3.2 mg/kg of the dopamine and noradrenaline receptor agonists apomorphine and clonidine, respectively. The accumulation of Dopa, as induced by the inhibitor of aromatic amino acid decarboxylase, NSD 1015, was measured in parallel in two dopamine-rich regions, i.e. the limbic system and the corpus striatum, and in two noradrenaline-rich regions, i.e. the neocortex and the lower brain stem. Low doses (0.025-0.2 mg/kg) of apomorphine reduced locomotion in a dose-dependent manner, while the reduction after higher doses was less pronounced, indicating a biphasic dose-response relationship. Clonidine caused a dose-dependent locomotor depression. When low doses of the two drugs were combined, the inhibitory effect observed was at least additive. When clonidine was combined with a high dose of apomorphine (0.8 mg/kg), it caused a significant inhibition of locomotion in a dose of 0.1-0.2 mg/kg, but not after 0.8 mg/kg, indicating a biphasic dose-response relationship. Either drug given alone reduced Dopa accumulation after inhibition of its decarboxylation, in all regions, but smaller doses of apomorphine had a clearcut effect only in the dopamine-rich regions, whereas the lowest dose of clonidine investigated (0.05 mg/kg) had an inhibitory effect on Dopa formation only in the neocortex. The relationship between the dose of apomorphine and Dopa formation in the neocortex appeared biphasic, the highest dose (3.2 mg/kg) having no significant effect. Further, apomorphine in this dose accelerated the disappearance of noradrenaline after inhibition of synthesis by alpha-methyltyrosine. Reversal of reserpine-induced suppression of motor activity was taken to indicate postsynaptic receptor activation. The threshold dose of apomorphine causing reversal was 0.2 mg/kg. The inhibitory effect of e.g. 0.05 mg/kg on locomotion and on Dopa formation suggests a preferential activation of inhibitory autoregulatory dopamine receptors by low doses of this drug. A similar trend was observed for clonidine. The basal importance of dopamine neurones for the locomotor function studied in the present paper is illustrated by the marked inhibition by low doses of apomorphine. On the other hand, the observations with clonidine suggest a somewhat less striking and perhaps less direct influence of noradrenaline neurones on motor activity. Mice with a low motor activity, as induced e.g. by reserpine or, in another experiment, mice adapted to the motility meter, displayed an increased motor activity after higher doses of apomorphine (from 0.2 and 2 mg/kg, respectively), whereas all doses depressed the initial high motor activity. Probably, high motor activity requires active dopamine neurones, making this behaviour more susceptible to interference with autoregulatory mechanisms, whereas a low basal activity may be more affected by activation of postsynaptic dopamine receptors.
分别给小鼠注射0.025 - 3.2毫克/千克的多巴胺和去甲肾上腺素受体激动剂阿扑吗啡和可乐定,测量其在活动度测量仪中前5分钟的运动活性。同时,在两个富含多巴胺的区域,即边缘系统和纹状体,以及两个富含去甲肾上腺素的区域,即新皮层和脑干下部,测量由芳香族氨基酸脱羧酶抑制剂NSD 1015诱导的多巴积累。低剂量(0.025 - 0.2毫克/千克)的阿扑吗啡以剂量依赖性方式降低运动活性,而高剂量后的降低则不太明显,表明存在双相剂量反应关系。可乐定引起剂量依赖性的运动抑制。当两种药物低剂量联合使用时,观察到的抑制作用至少是相加的。当可乐定与高剂量的阿扑吗啡(0.8毫克/千克)联合使用时,它在0.1 - 0.2毫克/千克的剂量下对运动有显著抑制作用,但在0.8毫克/千克后则没有,表明存在双相剂量反应关系。单独给予任何一种药物都会在抑制其脱羧后降低所有区域的多巴积累,但较小剂量的阿扑吗啡仅在富含多巴胺的区域有明显作用,而所研究的最低剂量的可乐定(0.05毫克/千克)仅在新皮层对多巴形成有抑制作用。新皮层中阿扑吗啡剂量与多巴形成之间的关系呈双相,最高剂量(3.2毫克/千克)没有显著影响。此外,在通过α - 甲基酪氨酸抑制合成后,该剂量的阿扑吗啡加速了去甲肾上腺素的消失。利血平诱导的运动活性抑制的逆转被视为突触后受体激活的指标。引起逆转的阿扑吗啡阈值剂量为0.2毫克/千克。例如,0.05毫克/千克对运动和多巴形成的抑制作用表明该药物低剂量优先激活抑制性自调节多巴胺受体。可乐定也观察到类似趋势。本文研究中低剂量阿扑吗啡的显著抑制作用说明了多巴胺神经元对运动功能的基础重要性。另一方面,可乐定的观察结果表明去甲肾上腺素神经元对运动活性的影响稍不显著且可能不那么直接。例如由利血平诱导的运动活性低的小鼠,或在另一个实验中适应活动度测量仪的小鼠,在给予较高剂量的阿扑吗啡(分别为0.2和2毫克/千克)后运动活性增加,而所有剂量都降低了最初的高运动活性。可能,高运动活性需要活跃的多巴胺神经元,使其行为更容易受到自调节机制干扰的影响,而低基础活性可能更受突触后多巴胺受体激活的影响。